tm logo
NEUKOPLAST
Live/Registered
REGISTERED AND RENEWED

on 06 Feb 2023

Last Applicant/ Owned by

3530 JOHN HOPKINS COURT

SAN DIEGO

CA

92121

Serial Number

85331364 filed on 26th May 2011

Registration Number

4187821 registered on 07th Aug 2012

in the Principal Register

Correspondent Address

Alicia M. Passerin

Alicia M. Passerin

525 William Penn Place, 28th Floor

Pittsburgh, PA 15219

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

NEUKOPLAST

Cells for medical or clinical use; pharmaceutical products for the prevention and treatment of cancer; therapeutic pharmaceutical for the treatment of cancer Cells for scientific, laboratory or medical research

Classification Information


Class [001]
Chemical Products


Cells for scientific, laboratory or medical research


First Use Date in General

26th Oct 2011

First Use Date in Commerce

26th Oct 2011

Class [005]
Pharmaceutical Products


Cells for medical or clinical use; pharmaceutical products for the prevention and treatment of cancer; therapeutic pharmaceutical for the treatment of cancer


First Use Date in General

21st Dec 2011

First Use Date in Commerce

21st Dec 2011

Mark Details


Serial Number

No 85331364

Mark Type

No Service/Collective Mark

Attorney Docket Number

No NKW-11-115

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
06th Feb 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06th Feb 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06th Feb 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06th Feb 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
20th Jul 2022TEAS SECTION 8 & 9 RECEIVED
07th Aug 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09th Jun 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
28th Sep 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
28th Sep 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
18th Sep 2018TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED